Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
    November 2021
  1. SHI D, Fan B, Sun B, Zhou J, et al
    LDH nanoparticle adjuvant subunit vaccine induces an effective immune response for porcine epidemic diarrhea virus.
    Virology. 2021;565:58-64.
    >> Share

    October 2021
  2. AHMED SM, Nasr MA, Elshenawy SE, Hussein AE, et al
    BCG vaccination and the risk of COVID 19: A possible correlation.
    Virology. 2021;565:73-81.
    >> Share

    August 2021
  3. MENNE Z, Pliasas VC, Compans RW, Glover S, et al
    Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model.
    Virology. 2021;562:197-208.
    >> Share

    July 2021
  4. KURT-JONES EA, Dudek TE, Watanabe D, Mandell L, et al
    Expression of SARS coronavirus 1 spike protein from a herpesviral vector induces innate immune signaling and neutralizing antibody responses.
    Virology. 2021;559:165-172.
    >> Share

    May 2021
  5. OH HS, Yoon JW, Lee S, Kim SO, et al
    A purified inactivated vaccine derived from Vero cell-adapted zika virus elicits protection in mice.
    Virology. 2021;560:124-130.
    >> Share

  6. CASE JB, Winkler ES, Errico JM, Diamond MS, et al
    On the road to ending the COVID-19 pandemic: Are we there yet?
    Virology. 2021;557:70-85.
    >> Share

    March 2021
  7. ABOU EL-FETOUH MS, Hafez MH, El-Attar ER, El-Agamy ME, et al
    Comparative bursal cytokine gene expression and apoptosis in vaccinated chickens following virulent infectious bursal disease virus challenge.
    Virology. 2021;558:126-133.
    >> Share

  8. LEE YH, Lim H, Lee JA, Kim SH, et al
    Optimization of Zika DNA vaccine by delivery systems.
    Virology. 2021;559:10-14.
    >> Share

    February 2021
  9. NOMURA N, Matsuno K, Shingai M, Ohno M, et al
    Updating the influenza virus library at Hokkaido University -It's potential for the use of pandemic vaccine strain candidates and diagnosis.
    Virology. 2021;557:55-61.
    >> Share

  10. ABDEL-MONEIM AS, Abdelwhab EM, Memish ZA
    Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines.
    Virology. 2021;558:1-12.
    >> Share

  11. READ CM, Plante K, Rafael G, Rossi SL, et al
    Designing multivalent immunogens for alphavirus vaccine optimization.
    Virology. 2021 Feb 5. pii: S0042-6822(20)30236.
    >> Share

    December 2020
  12. OJWACH DBA, Madlala P, Gordon M, Ndung'u T, et al
    Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.
    Virology. 2020;554:1-8.
    >> Share

    October 2020
  13. DEVANT JM, Hansman GS
    Structural heterogeneity of a human norovirus vaccine candidate.
    Virology. 2020;553:23-34.
    >> Share

    September 2020
  14. WIECZOREK L, Peachman K, Steers N, Schoen J, et al
    Selection and immune recognition of HIV-1 MPER mimotopes.
    Virology. 2020;550:99-108.
    >> Share

    August 2020
  15. KIM KH, Jung YJ, Lee Y, Park BR, et al
    Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.
    Virology. 2020;550:51-60.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016